The Community Physician’s Place in Pharm’s Emerging Commercial Model
Recent industry scrutiny and legislation (e.g., Physician Payments Sunshine Act, IMAP, etc.) have limited physician access. Physicians who will see reps are demanding “greater value and more service” which is causing shifts in how pharma approaches physicians with a new emphasis on physician satisfaction and building relationships.
PharmaVoice recently published “From KOL to COL: Regional Influencers Are Critical To Commercial Model Re-Invention” featuring Qforma. This article provides a potential avenue to address the issue of diminishing physician access by shifting focus from KOLs to COLs. Learn more about how dramatic shifts in the pharmaceutical commercial model have forced marketers to explore more effective conduits for accessing physicians by reading the article below.
